Overall, we suggested that tumor angiogenesis in renal cancer cell could be inhibited by SLC39A1 through downregulating ANGPTL4, and inactivated PPAR signal pathway was the underlying mechanism. The gene discussed is ANGPTL4; the disease is renal carcinoma.